Cumulative evidence indicates that mTOR signaling pathway has become an attractive target for cancer therapy and targeting mTOR signaling has been exploited as a promising tumor-selective therapeutic strategy [11, 12, 19, 20]. The gene discussed is MTOR; the disease is neoplasm.